Evidence map›Paper›PMID 36281051›Full record

ArticleThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2022

Quantification of multidrug-resistant

S E Smith-Jeffcoat, K D Eisenach, M Joloba, W Ssengooba, C Namaganda, M Nsereko, B Okware, J S Cavanaugh, J P Cegielski

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

S E Smith-JeffcoatDivision of Global HIV/AIDS and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.
K D EisenachTB or NOT TB Consulting, Little Rock, AR, USA.
M JolobaDepartment of Medical Microbiology and Biomedical Research Center, Makerere University, Kampala, Uganda.
W SsengoobaDepartment of Medical Microbiology and Biomedical Research Center, Makerere University, Kampala, Uganda.
C NamagandaDepartment of Medical Microbiology and Biomedical Research Center, Makerere University, Kampala, Uganda.
M NserekoUganda-Case Western Research Unit Research Collaboration, Kampala, Uganda.
B OkwareUganda-Case Western Research Unit Research Collaboration, Kampala, Uganda.
J S CavanaughDivision of Global HIV/AIDS and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.
J P CegielskiDivision of Global HIV/AIDS and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Makerere University · UGCenter for Global Health · USInfectious Diseases Research Collaboration · UGCenters for Disease Control and Prevention · US

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Mycobacterium tuberculosisTuberculosis, Multidrug-ResistantTuberculosis, PulmonaryAdultAgarFemaleHumansMaleSputumUgandaAgar

Identifiers

PMID36281051
PMCPMC9720669
OpenAlexW4307339208

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.